LifeVantage
August 28, 2023
Salt Lake City, UT, August 28, 2023 --
LifeVantage Corporation reported fiscal fourth-quarter revenue of 54.2 million dollars for the period ended June 30, 2023, up 6.4 percent from a year earlier, or about 7.8 percent excluding currency. Americas revenue rose 17.9 percent, including an 18.6 percent increase in the United States, while Asia/Pacific and Europe fell 16.0 percent, or about 3.9 percent in constant currency.
Net income was 2.0 million dollars, or 0.15 dollars per diluted share, versus a loss of 0.11 dollars a year earlier. Adjusted EPS was 0.17 dollars and adjusted EBITDA was 4.8 million dollars. Full-year fiscal 2023 revenue rose 3.4 percent to 213.4 million dollars. Cash was 21.6 million dollars with no debt.
President and chief executive Steve Fife said LV360 initiatives and TrueScience Liquid Collagen momentum drove U.S. growth. The board declared a special cash dividend of 0.40 dollars per share plus the regular 0.035 dollar quarterly dividend, both payable September 22, 2023. Fiscal 2024 guidance is revenue of 216 million to 226 million dollars and adjusted EBITDA of 16 million to 18 million dollars.